CMV-specific T-Cells for Treatment of CMV infection after hematopoietic stem cell transplantation in a pediatric case: First application in Turkey
MetadataShow full item record
CitationBao, Y., Huang, S., & Zhao, Z. (2020). Comparison of Different Culture Conditions for Mesenchymal Stem Cells from Human Umbilical Cord Wharton’s Jelly for Stem Cell Therapy. Turk J Hematol, 37, 57-76.
Cytomegalovirus (CMV) infection is still a major complication after allogeneic hematopoietic stem cell transplantation (HSCT) [1,2]. Unfortunately, prolonged antiviral treatment of CMV infection causes a delayed CMV-specific immune reconstitution. At this point, adoptive immunotherapy by CMV-specific T-cells can control CMV infection or provide immune reconstruction